Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Doctors need more training in skin cancer screening, a new treatment is effective for a skin condition, better diagnosis methods for skin cancer are available, hair loss in women may be linked to hormones and cholesterol, certain skin care products might cause hair loss, babies' skin gets weaker after birth, and a gene mutation might be linked to eczema.

Hirsutism in GCC countries is influenced by genetics, obesity, and lifestyle, with cultural stigma delaying treatment, highlighting the need for tailored health strategies.

Aesthetic medicine is focusing more on patient needs and using new technologies, but ethical issues and regulation challenges need attention.

Centralized imaging provides more accurate and consistent hair loss measurements in alopecia areata.

Janus kinase inhibitors can help children with alopecia areata regrow hair but may have some risks.

Isotretinoin is effective for severe acne but requires careful monitoring for side effects, especially in women who could become pregnant.

The review found that current care models for PCOS are not fully effective and more research is needed, especially in low-income countries.

Mutations in the RBPJ gene cause Adams-Oliver Syndrome.

Dermatoscopy is a useful tool for diagnosing hair disorders and can help choose samples for more detailed analysis.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

A specific genetic change in the KRT71 gene causes a hair loss condition in Hereford cattle.

3D bioprinting is useful for making tissues, testing drugs, and delivering drugs, but needs better materials, resolution, and scalability.

Caffeine may be good for hair growth and skin care because it binds well with keratin.

A 3D skin model helps study wound healing better than traditional methods.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

The AI showed high accuracy in diagnosing skin conditions but needs improvement for immunological and infectious disorders.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

Tofacitinib is an effective and safe treatment for alopecia areata.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Dermoscopy is a useful tool for identifying features of skin conditions, but more research is needed to define its role in dermatology.

Multiphoton microscopy is a promising tool for detailed skin imaging and could improve patient care if its challenges are addressed.

The BHBS is a valid tool to study cultural norms and breast cancer risk in Black women.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

The DiLiCre mouse model is an effective tool for precise genome editing using light.

The EQ-5D-5L tool may not accurately measure the impact of alopecia areata on patients' lives.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Vitamin D3 helps treat mild to moderate alopecia areata, especially when combined with other treatments.

New methods may speed up drug development for male subfertility.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.